Related Articles
Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma
The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma
Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway
miR‑375/Yes‑associated protein axis regulates IL‑6 and TGF‑β expression, which is involved in the cisplatin‑induced resistance of liver cancer cells
Yes‑associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma (Review)